These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38804779)

  • 1. Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention.
    Du Toit G; Huffaker MF; Radulovic S; Feeney M; Fisher HR; Byron M; Dunaway L; Calatroni A; Johnson M; Foong RX; Marques-Mejias A; Bartha I; Basting M; Brough HA; Baloh C; Laidlaw TM; Bahnson HT; Roberts G; Plaut M; Wheatley LM; Lack G;
    NEJM Evid; 2024 Jun; 3(6):EVIDoa2300311. PubMed ID: 38804779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Avoidance on Peanut Allergy after Early Peanut Consumption.
    Du Toit G; Sayre PH; Roberts G; Sever ML; Lawson K; Bahnson HT; Brough HA; Santos AF; Harris KM; Radulovic S; Basting M; Turcanu V; Plaut M; Lack G;
    N Engl J Med; 2016 Apr; 374(15):1435-43. PubMed ID: 26942922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of peanut consumption in infants at risk for peanut allergy.
    Du Toit G; Roberts G; Sayre PH; Bahnson HT; Radulovic S; Santos AF; Brough HA; Phippard D; Basting M; Feeney M; Turcanu V; Sever ML; Gomez Lorenzo M; Plaut M; Lack G;
    N Engl J Med; 2015 Feb; 372(9):803-13. PubMed ID: 25705822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
    Jones SM; Kim EH; Nadeau KC; Nowak-Wegrzyn A; Wood RA; Sampson HA; Scurlock AM; Chinthrajah S; Wang J; Pesek RD; Sindher SB; Kulis M; Johnson J; Spain K; Babineau DC; Chin H; Laurienzo-Panza J; Yan R; Larson D; Qin T; Whitehouse D; Sever ML; Sanda S; Plaut M; Wheatley LM; Burks AW;
    Lancet; 2022 Jan; 399(10322):359-371. PubMed ID: 35065784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of tolerance to egg and peanut in African food-allergic children with atopic dermatitis.
    Gray CL; Levin ME; Du Toit G
    S Afr Med J; 2019 Apr; 109(5):323-327. PubMed ID: 31131799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking the leap earlier: the timing of tolerance.
    Young MC
    Curr Opin Pediatr; 2015 Dec; 27(6):736-40. PubMed ID: 26474341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment.
    Peters RL; Allen KJ; Dharmage SC; Koplin JJ; Dang T; Tilbrook KP; Lowe A; Tang ML; Gurrin LC;
    J Allergy Clin Immunol; 2015 May; 135(5):1257-66.e1-2. PubMed ID: 25725989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Introduction of Food Allergens and Risk of Developing Food Allergy.
    Yakaboski E; Robinson LB; Arroyo A; Espinola JA; Geller RJ; Sullivan AF; Rudders SA; Camargo CA
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction.
    Greenhawt M; Fleischer DM; Chan ES; Venter C; Stukus D; Gupta R; Spergel JM
    Allergy; 2017 Aug; 72(8):1254-1260. PubMed ID: 27896827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses.
    Grabenhenrich L; Lange L; Härtl M; Kalb B; Ziegert M; Finger A; Harandi N; Schlags R; Gappa M; Puzzo L; Stephan V; Heigele T; Büsing S; Ott H; Niggemann B; Beyer K
    J Allergy Clin Immunol; 2016 Jun; 137(6):1751-1760.e8. PubMed ID: 27087317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
    Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut component Ara h 8 sensitization and tolerance to peanut.
    Asarnoj A; Nilsson C; Lidholm J; Glaumann S; Östblom E; Hedlin G; van Hage M; Lilja G; Wickman M
    J Allergy Clin Immunol; 2012 Aug; 130(2):468-72. PubMed ID: 22738678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early epitope-specific IgE antibodies are predictive of childhood peanut allergy.
    Suprun M; Sicherer SH; Wood RA; Jones SM; Leung DYM; Henning AK; Dawson P; Burks AW; Lindblad R; Getts R; Suárez-Fariñas M; Sampson HA
    J Allergy Clin Immunol; 2020 Nov; 146(5):1080-1088. PubMed ID: 32795587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising the management of peanut allergy by targeting immune plasticity.
    Nguyen A; du Toit G; Lack G; Marrs T
    Clin Exp Allergy; 2024 Mar; 54(3):169-184. PubMed ID: 38423799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Antigen-Specific Immunoglobulin E Immunoassays against Ara h 2 and Ara h 8 Peanut Components in Child Food Allergy.
    Martinet J; Couderc L; Renosi F; Bobée V; Marguet C; Boyer O
    Int Arch Allergy Immunol; 2016; 169(4):216-22. PubMed ID: 27225199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort.
    du Toit G; Sayre PH; Roberts G; Lawson K; Sever ML; Bahnson HT; Fisher HR; Feeney M; Radulovic S; Basting M; Plaut M; Lack G;
    J Allergy Clin Immunol; 2018 Apr; 141(4):1343-1353. PubMed ID: 29097103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors associated with peanut allergy in a high-risk infant cohort.
    Sicherer SH; Wood RA; Perry TT; Jones SM; Leung DYM; Henning AK; Dawson P; Burks AW; Lindblad R; Sampson HA
    Allergy; 2019 Nov; 74(11):2199-2211. PubMed ID: 31120555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of peanut sensitization following exposure through breast-feeding and early peanut introduction.
    Pitt TJ; Becker AB; Chan-Yeung M; Chan ES; Watson WTA; Chooniedass R; Azad MB
    J Allergy Clin Immunol; 2018 Feb; 141(2):620-625.e1. PubMed ID: 28916221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ara h2 levels in dust from homes of individuals with peanut allergy and individuals with peanut tolerance.
    Shroba J; Barnes C; Nanda M; Dinakar C; Ciaccio C
    Allergy Asthma Proc; 2017 May; 38(3):192-196. PubMed ID: 28441989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.